An association between adiposity and serum levels of macrophage inflammatory protein-1α and soluble CD14 in HIV-infected adults: Results from a crosssectional study

Antiviral Therapy

Volumn 18, Issue 5, 2013, Pages 729-733

  Koethe, John R ^a   Bian, Aihua ^a   Shintani, Ayumi K ^a   Wester, C William ^a,b   Erdem, Husamettin ^a   Hulgan, Todd ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIRETROVIRUS AGENT; C REACTIVE PROTEIN; CD14 ANTIGEN; CYTOKINE RECEPTOR; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR 1; TUMOR NECROSIS FACTOR ALPHA RECEPTOR 2; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FAT MASS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OBESITY; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING HABIT;

ADIPOSE TISSUE; ADIPOSITY; ADULT; ANTIGENS, CD14; CD4 LYMPHOCYTE COUNT; CHEMOKINE CCL3; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; VIRAL LOAD;

EID: 84888150953     PISSN: 13596535     EISSN: 20402058     Source Type: Journal    
DOI: 10.3851/IMP2645     Document Type: Article

References (21)

1. Reingold J, Wanke C, Kotler D, et al. Association of HIV infection and HIV/HCV coinfection with C-reactive protein levels: the fat redistribution and metabolic change in HIV infection (FRAM) study. J Acquir Immune Defic Syndr 2008;48:142-148.
2. Koethe JR, Bian A, Shintani AK, et al. Serum leptin level mediates the association of body composition and serum C-reactive protein in HIV-infected persons on antiretroviral therapy. AIDS Res Hum Retroviruses 2012;28:552-557.
3. Deeks SG. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med 2011;62:141-155.
4. Kuller LH, Tracy R, Belloso W, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 2008;5:e203.
5. Shikuma CM, Ribaudo HJ, Zheng Y, et al. Change in high-sensitivity C-reactive protein levels following initiation of efavirenz-based antiretroviral regimens in HIV-Infected individuals. AIDS Res Hum Retroviruses 2011;27:461-468.
6. Ford ES, Greenwald JH, Richterman AG, et al. Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection. AIDS 2010;24:1509-1517.
7. Brown TT, Tassiopoulos K, Bosch RJ, Shikuma C, McComsey GA. Association between systemic inflammation and incident diabetes in HIV-infected patients after initiation of antiretroviral therapy. Diabetes Care 2010;33:2244-2249.
8. Triant VA, Meigs JB, Grinspoon SK. Association of C-reactive protein and HIV infection with acute myocardial infarction. J Acquir Immune Defic Syndr 2009;51:268-273.
9. Boger MS, Shintani A, Redhage LA, et al. Highly sensitive C-reactive protein, body mass index, and serum lipids in HIV-infected persons receiving antiretroviral therapy: a longitudinal study. J Acquir Immune Defic Syndr 2009;52:480-487.
10. Institute for Statistics and Mathematics of Wirtschaftsuniversität Wien. The R project for statistical computing. (Updated 22 July 2013. Accessed 24 July 2013.) Available from http://www.r-project.org
11. Bian A. Vanderbilt University Department of Biostatics Archived Analyses. (Update 24 August 2012. Accessed 24 July 2013.) Available from http://biostat.mc.vanderbilt.edu/wiki/pub/Main/ArchivedAnalyses/JohnRoCytokine. R
12. Duprez DA, Neuhaus J, Kuller LH, et al. Inflammation, coagulation and cardiovascular disease in HIV-infected individuals. PLoS ONE 2012;7:e44454.
13. Bruun JM, Lihn AS, Pedersen SB, Richelsen B. Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. J Clin Endocrinol Metab 2005;90:2282-2289.
14. Lee YH, Nair S, Rousseau E, et al. Microarray profiling of isolated abdominal subcutaneous adipocytes from obese vs non-obese Pima Indians: increased expression of inflammationrelated genes. Diabetologia 2005;48:1776-1783.
15. Skurk T, Alberti-Huber C, Herder C, Hauner H. Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 2007;92:1023-1033.
16. Weisberg SP, McCann D, Desai M, et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112:1796-1808.
17. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006;12:1365-1371.
18. Bas S, Gauthier BR, Spenato U, Stingelin S, Gabay C. CD14 is an acute-phase protein. J Immunol 2004;172:4470-4479.
19. Landmann R, Knopf HP, Link S, et al. Human monocyte CD14 is upregulated by lipopolysaccharide. Infect Immun 1996;64:1762-1769.
20. Arias MA, Rey Nores JE, Vita N, et al. Cutting edge: human B cell function is regulated by interaction with soluble CD14: opposite effects on IgG1 and IgE production. J Immunol 2000;164:3480-3486.
21. ReyNores JE, Bensussan A, Vita N, et al. Soluble CD14 acts as a negative regulator of human T cell activation and function. Eur J Immunol 1999;29:265-276.